Literature DB >> 16449694

Two-week delay in onset of action of antidepressants: new evidence.

Alex J Mitchell.   

Abstract

Many sources purport that antidepressants have a delayed onset of action, measured in weeks rather than days. Recent data using weekly or daily mood ratings demonstrate that maximum improvement occurs during the first 2 weeks, with some improvement within the first 3 days. Methodological issues may underlie the delayed-onset hypothesis.

Mesh:

Substances:

Year:  2006        PMID: 16449694     DOI: 10.1192/bjp.bp.105.011692

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  18 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

3.  A Computational Model of Major Depression: the Role of Glutamate Dysfunction on Cingulo-Frontal Network Dynamics.

Authors:  Juan P Ramirez-Mahaluf; Alexander Roxin; Helen S Mayberg; Albert Compte
Journal:  Cereb Cortex       Date:  2017-01-01       Impact factor: 5.357

4.  Social fear conditioning: a novel and specific animal model to study social anxiety disorder.

Authors:  Iulia Toth; Inga D Neumann; David A Slattery
Journal:  Neuropsychopharmacology       Date:  2012-01-11       Impact factor: 7.853

5.  Analysis of region-specific changes in gene expression upon treatment with citalopram and desipramine reveals temporal dynamics in response to antidepressant drugs at the transcriptome level.

Authors:  Magdalena Gąska; Maciej Kuśmider; Joanna Solich; Agata Faron-Górecka; Małgorzata J Krawczyk; Krzysztof Kułakowski; Marta Dziedzicka-Wasylewska
Journal:  Psychopharmacology (Berl)       Date:  2012-05-01       Impact factor: 4.530

6.  Initial rate of improvement in relation to remission of major depressive disorder in primary care.

Authors:  Anton C Vergouwen; Huibert Burger; Frank Koerselman; Theo J Verheij
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  Oppositional effects of serotonin receptors 5-HT1a, 2, and 2c in the regulation of adult hippocampal neurogenesis.

Authors:  Friederike Klempin; Harish Babu; Davide De Pietri Tonelli; Edson Alarcon; Klaus Fabel; Gerd Kempermann
Journal:  Front Mol Neurosci       Date:  2010-07-30       Impact factor: 5.639

8.  Association of Novel ALX4 Gene Polymorphisms with Antidepressant Treatment Response: Findings from the CO-MED Trial.

Authors:  Bharathi S Gadad; Prithvi Raj; Manish K Jha; Thomas Carmody; Igor Dozmorov; Taryn L Mayes; Edward K Wakeland; Madhukar H Trivedi
Journal:  Mol Neuropsychiatry       Date:  2018-05-03

Review 9.  Translating the promise of 5HT4 receptor agonists for the treatment of depression.

Authors:  Susannah E Murphy; Angharad N de Cates; Amy L Gillespie; Beata R Godlewska; Jessica C Scaife; Lucy C Wright; Philip J Cowen; Catherine J Harmer
Journal:  Psychol Med       Date:  2020-04-03       Impact factor: 7.723

Review 10.  Elucidating the Possible Role of FoxO in Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Vineet Mehta; Sukhbir Singh; Neelam Sharma; Simona Bungau
Journal:  Neurochem Res       Date:  2021-06-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.